Calcivis Limited, an Edinburgh-based dental technology company, has entered administration. The firm, which employed nine staff, was known for developing a patented bioluminescence system designed to help prevent cavities and tooth decay.
David McGinness and Judith Howson of AAB Business & Tax Advisory were appointed as joint administrators on September 25, 2026, according to a London Gazette notice. The company had been established in 2012.
Funding and Investment History
Calcivis had received both public and private funding over the years. The Scottish National Investment Bank (SNIB) committed £5 million in 2024. Since its founding, the firm raised more than £18 million in total funding.
Other investors included Scottish Enterprise and Archangels, which describes itself as "the world's longest running business angel investment syndicate." Despite this backing, the company was "unable to scale its commercialisation to build a sustainable business."
Administrators' Statement
As reported by The Herald, administrators said that "despite the progress made by the business and the quality of its underlying technology, the company was unable to bridge to profitability sufficiently quickly and continued to experience pressure on cashflow."
A spokesperson for AAB said: "Prior to the appointment, the directors undertook an accelerated marketing process to seek a sale of the business and assets. While there was interest in the company and its technology, no deliverable solvent sale or funding solution was capable of being completed within the available timeframe.
"Mindful of their duties and responsibilities to creditors, the directors therefore took the difficult decision to cease to trade and seek the appointment of administrators."
Next Steps and Creditor Information
The joint administrators are now "assessing the company's position and will seek to realise the remaining assets for the benefit of creditors." Creditors will be contacted "in due course," and enquiries should be directed to Rob Hardie.
The administrators will also "provide affected employees at this difficult time with information and support to enable them to submit claims for any statutory entitlements, including arrears of pay, holiday pay, notice pay and redundancy pay, where applicable, through the Redundancy Payments Service."
A SNIB spokesperson said: "Despite the market potential of its innovative dental diagnostic device, regrettably, Calcivis has filed for administration. The bank worked with Calcivis and other stakeholders to support its commercialisation efforts and later to explore a potential partnership or sale to realise the full benefits of the technology.
"Risk is inherent in all investments, and as Scotland's development bank, we were mandated to take on higher risk than other commercial investors in order to fill an identified gap in the Scottish funding landscape. Some failures are inevitable, and our strategy is based on the entire portfolio over the long term. The bank made a provision for the potential closure of the company in its recent annual report and accounts as part of its unrealised losses."
A spokesperson for Archangels said: "We are sad to see that Calcivis has entered administration. Archangels has supported the company since 2012, backing it through several funding rounds as the team worked to bring an innovative dental technology to market.
"Despite the commitment of everyone involved, against the backdrop of challenging dental markets, Calcivis was unable to scale its commercialisation to build a sustainable business. Backing early-stage innovation means accepting that not every company will succeed, and we remain committed to supporting Scotland's most promising technology and life science businesses."
